A Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination with and without MVA85A Boost in Healthy BCG Vaccinated Adults
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs ChAdOx1 85A (Primary) ; MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 18 Aug 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
- 18 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.